The Effect of the Neutropenic Diet in the Outpatient Setting: A Pilot Study

Debra DeMille

Priscilla Deming

Paul Lupinacci

Linda A. Jacobs

ONF 2006, 33(2), 337-343. DOI: 10.1188/ONF.06.337-343

Purpose/Objectives: To determine whether use of the neutropenic diet in the outpatient setting decreases the number of febrile admissions and positive blood cultures associated with chemotherapy-induced neutropenia.

Design: Descriptive pilot study.

Setting: Outpatient chemotherapy unit of a medical center in a major metropolitan area.

Sample: Convenience sample of 28 patients aged 33-67 years beginning treatment with 1 of 13 chemotherapy regimens.

Methods: Twelve-week prospective study beginning on day 1 of chemotherapy cycle 1. Patients received instructions regarding the neutropenic diet before starting chemotherapy. Adherence assessment telephone calls were made at weeks 6 and 12. Hospital admission charts were reviewed at study completion.

Main Research Variables: Adherence with neutropenic diet, number of febrile admissions, and number of positive blood cultures.

Findings: Sixteen patients were compliant with the neutropenic diet, four of which were admitted for neutropenia with gram-negative rods. No significant differences were found in the rates of febrile admissions or positive blood cultures between compliant and noncompliant patients.

Conclusions: Clinical significance in this pilot study is related to the time required for diet education, content of diet education regarding food restrictions, and difficulty adhering to diet requirements given the multitude of side effects (e.g., nausea, vomiting, mouth sores, diarrhea) of chemotherapy.

Implications for Nursing: No clear evidence exists that the neutropenic diet makes a difference in overall rates of infection. Nursing research to compare the neutropenic diet with a less restrictive food safety education- focused diet is needed to guide clinical practice.

Jump to a section


    Aker, S.N., & Cheney, C.L. (1983). The use of sterile and low microbial diets in ultraisolation environments.Journal of Parenteral and Enteral Nutrition, 7, 390-397.

    American Dietetic Association. (1997). Safe eating: A guide to preventing food-borne illness [Brochure]. Chicago, IL: Author.

    Baehner, R.L. (2004). Overview of neutropenia. Retrieved on June 28, 2004, from

    Bodey, G.P., Hart, J., Freireich, E.J., & Frei, E., III. (1968). Studies of a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. Cancer, 22, 1018-1026.

    Bodey, G.P., Rodriguez, V., Murry, W.K., Burgess, M.A., & Benjamin, R.S. (1981). Protected environment-Prophylactic antibiotic program for malignant sarcomas: Randomized trial during remission induction chemotherapy. Cancer, 47, 2422-2429.

    Brandt, B. (1990). Nursing protocol for the patient with neutropenia. Oncology Nursing Forum, 17(1, Suppl.), 9-15.

    Buckner, C.D., Clift, R.A., Sanders, J.E., Meyers, J.D., Counts, G.W., Farewell, V.T., et al. (1978). Protective environment for marrow transplant recipients: A prospective study.Annals of Internal Medicine, 89, 893-901.

    Carter, L.W. (1993). Influences of nutrition and stress on people at risk for neutropenia: Nursing implications.Oncology Nursing Forum, 20, 1241-1250.

    Carter, L.W. (1994). Bacterial translocation: Nursing implications in the care of patients with neutropenia. Oncology Nursing Forum, 21, 857-865.

    Denzenhall, A., Curry-Bartley, K., Blackburn, S.A., De Lamerens, S., & Khan, A.R. (1987). Food and nutrition services in bone marrow transplant centers. Journal of the American Dietetic Association, 87, 1351-1353.

    Fenelon, L.E. (1995). Protective isolation: Who needs it? Journal of Hospital Infection, 30(Suppl.), 218-222.

    Fishman, M., & Mrozek-Orlowski, M. (Eds.). (1999). Cancer chemotherapy guidelines and recommendations for practice (2nd ed.). Pittsburgh, PA: Oncology Nursing Society.

    French, M.R., Levy-Milne, R., & Zibrik, D. (2001). A survey of the use of low microbial diets in pediatric bone marrow transplant programs. Journal of the American Dietetic Association, 101, 1194-1198.

    Gaytan-Martinez, J., Mateos-Carcia, E., Sanchez-Cortes, E., Gonzalez- Llaven, J., Casanova-Cardiel, L.J., & Fuentes-Allen, J.L. (2000). Microbiological findings in febrile neutropenia. Archives of Medical Research, 31, 388-392.

    Greifzu, S. (1991). Helping cancer patients fight infection. RN, 54 (7), 24-29.

    Levine, A.S., Siegel, S.E., Schreiber, A.D., Hauser, J., Preisler, H., Goldstein, I.M., et al. (1973). Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. New England Journal of Medicine, 288, 477-483.

    Levitan, A.A., & Perry, S. (1967). Infectious complications of chemotherapy in a protected environment. New England Journal of Medicine, 276, 881-886.

    Lynch, J., Jameson, B., Gamble, D.R., & Kay, H.E. (1971). Five-year analysis of protective isolation. Lancet, 1, 1034-1040.

    McCallum, P.D., & Polisena, C. (Eds.). (2000). The clinical guide to oncology nutrition. Chicago: American Dietetic Association.

    Moe, G. (1990). Low microbial diets for patients with granulocytopenia. In A.S. Bloch (Ed.). Nutrition management of the cancer patient (pp. 125-134). Rockville, MD: Aspen.

    Moody, K., Charlson, M.E., & Finlay, J. (2002). The neutropenic diet: What's the evidence? Journal of Pediatric Hematology/Oncology, 24, 717-721.

    Pizzo, P.A. (1981). The value of protective isolation in preventing nosocomial infections in high risk patients. American Journal of Medicine, 70, 631-637.

    Pizzo, P.A. (1984). Granulocytopenia and cancer therapy: Past problems, current solutions, future challenges. Cancer, 54(11, Suppl.), 2649-2661.

    Pizzo, P.A., Purvis, D.S., & Waters, C. (1982). Microbiological evaluation of food items. For patients undergoing gastrointestinal decontamination and protected isolation.Journal of the American Dietetic Association, 81, 272-279.

    Preisler, H.D., Goldstein, I.M., & Henderson, E.S. (1970). Gastrointestinal "sterilization" in the treatment of patients with acute leukemia. Cancer, 26, 1076-1081.

    Remington, J.S., & Schimpff, S.C. (1981). Occassional notes. Please don't eat the salads New England Journal of Medicine, 304, 433-435.

    Schimpff, S.C., Greene, W.H., Young, V.M., Fortner, C.L., Cusack, N., Block, J.B., et al. (1975). Infection prevention in acute nonlymphocytic leukemia. Annals of Internal Medicine, 82, 351-358.

    Schwartz, S.A., & Perry, S. (1966). Patient protection in cancer chemotherapy. JAMA, 197, 623-627.

    Shooter, R.A., Cooke, E.M., Faiers, M.C., Breaden, A.L., & O'Farrell, S.M. (1971). Isolation of Escherichia coli, Pseudomonas aeruginosa, and Klebsiella from food in hospitals, canteens, and schools. Lancet, 2, 390-392.

    Shooter, R.A., Gaya, H., Cooke, E.M., Kumar, P., Patel, N., Parker, M.T., et al. (1969). Food and medicaments as possible sources of hospital strains of pseudomonas aeruginosa. Lancet, 1, 1227-1229.

    Smith, L.H., & Besser, S.G. (2000). Dietary restrictions for patients with neutropenia: A survey of institutional practices. Oncology Nursing Forum, 27, 515-520.

    Somerville, E.T. (1986). Special diets for neutropenic patients: Do they make a difference? Seminars in Oncology Nursing, 2, 55-58.

    Todd, J., Schmidt, M., Christain, J., & Williams, R. (1999). The low-bacteria diet for immunocompromised patients: Reasonable prudence or clinical superstition? Cancer Practice, 7, 205-207.

    Weihofen, D.L., & Marino, C. (1998). The cancer survival cookbook. New York: John Wiley and Sons.

    Yates, J.W., & Holland, J.F. (1973). A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer, 32, 1490-1498.